BRIEF-Aurobindo Pharma gets FDA nod for generic version of Reckitt Benckiser’s Mucinex DM tablets

Last Updated: Mon, Mar 20, 2017 18:00 hrs

March 20 (Reuters) - Aurobindo Pharma Ltd

* Says Aurobindo Pharma receives USFDA approval for guaifenesin and dextromethorphan hydrobromide

* Says the product will be launched in Q1FY18.

* guaifenesin and dextromethorphan hydrobromide extended-release tablets are AB rated generic equivalent of Reckitt Benckiser’S Mucinex DM tablets

* Guaifenesin and dextromethorphan hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions Source text: http://bit.ly/2nVtboi Further company coverage:



More from Sify: